These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30724102)

  • 21. Systematic Review of Patient Decision Aids for Stroke Prevention Therapy in Atrial Fibrillation Management.
    Baers JH; Adekanye J; Hazlewood G; Davies JM; Caird JK; Wilton SB
    Rev Cardiovasc Med; 2022 Oct; 23(10):353. PubMed ID: 39077149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of Complementary Encounter and Patient Decision Aids for Shared Decision Making about Stroke Prevention in Atrial Fibrillation.
    Jones AE; McCarty MM; Cameron KA; Cavanaugh KL; Steinberg BA; Passman R; Kansal P; Guzman A; Chen E; Zhong L; Fagerlin A; Hargraves I; Montori VM; Brito JP; Noseworthy PA; Ozanne EM
    MDM Policy Pract; 2023; 8(1):23814683231178033. PubMed ID: 38178866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Personalized, Electronic Health Record-Integrated Decision Aid for Stroke Prevention in Atrial Fibrillation: A Small Cluster Randomized Trial and Qualitative Analysis of Efficacy and Acceptability.
    Schott SL; Berkowitz J; Dodge SE; Petersen CL; Saunders CH; Sobti NK; Xu K; Coylewright M
    Circ Cardiovasc Qual Outcomes; 2021 Jun; 14(6):e007329. PubMed ID: 34107740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shared decision-making tool for thromboprophylaxis in atrial fibrillation - A feasibility study.
    Eckman MH; Costea A; Attari M; Munjal J; Wise RE; Knochelmann C; Flaherty ML; Baker P; Ireton R; Harnett BM; Leonard AC; Steen D; Rose A; Kues J
    Am Heart J; 2018 May; 199():13-21. PubMed ID: 29754650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A patient decision aid to support shared decision-making on anti-thrombotic treatment of patients with atrial fibrillation: randomised controlled trial.
    Thomson RG; Eccles MP; Steen IN; Greenaway J; Stobbart L; Murtagh MJ; May CR
    Qual Saf Health Care; 2007 Jun; 16(3):216-23. PubMed ID: 17545350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient preferences regarding atrial fibrillation stroke prophylaxis in patients at potential risk of atrial fibrillation.
    Edwards NT; Greanya ED; I Fan Kuo ; Loewen PS; Culley CL
    Int J Clin Pharm; 2017 Apr; 39(2):468-472. PubMed ID: 28281227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral Anticoagulation in Atrial Fibrillation: Development and Evaluation of a Mobile Health Application to Support Shared Decision-Making.
    Stephan LS; Almeida ED; Guimarães RB; Ley AG; Mathias RG; Assis MV; Leiria TLL
    Arq Bras Cardiol; 2018 Jan; 110(1):7-15. PubMed ID: 29412241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis.
    van Walraven C; Hart RG; Singer DE; Laupacis A; Connolly S; Petersen P; Koudstaal PJ; Chang Y; Hellemons B
    JAMA; 2002 Nov; 288(19):2441-8. PubMed ID: 12435257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using an Atrial Fibrillation Decision Support Tool for Thromboprophylaxis in Atrial Fibrillation: Effect of Sex and Age.
    Eckman MH; Lip GY; Wise RE; Speer B; Sullivan M; Walker N; Kissela B; Flaherty ML; Kleindorfer D; Baker P; Ireton R; Hoskins D; Harnett BM; Aguilar C; Leonard A; Arduser L; Steen D; Costea A; Kues J
    J Am Geriatr Soc; 2016 May; 64(5):1054-60. PubMed ID: 27225358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of decision aids on patient preferences for anticoagulant therapy: a randomized trial.
    Holbrook A; Labiris R; Goldsmith CH; Ota K; Harb S; Sebaldt RJ
    CMAJ; 2007 May; 176(11):1583-7. PubMed ID: 17515584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visual Aid Tool to Improve Decision Making in Anticoagulation for Stroke Prevention.
    Saposnik G; Joundi RA
    J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2380-5. PubMed ID: 27318647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shared Decision Making Tools for People Facing Stroke Prevention Strategies in Atrial Fibrillation: A Systematic Review and Environmental Scan.
    Torres Roldan VD; Brand-McCarthy SR; Ponce OJ; Belluzzo T; Urtecho M; Espinoza Suarez NR; Toloza FJK; Thota AD; Organick PW; Barrera F; Liu-Sanchez C; Jaladi S; Prokop L; Ozanne EM; Fagerlin A; Hargraves IG; Noseworthy PA; Montori VM; Brito JP
    Med Decis Making; 2021 Jul; 41(5):540-549. PubMed ID: 33896270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decision-making around antithrombotics for stroke prevention in atrial fibrillation: the health professionals' views.
    Wang Y; Bajorek B
    Int J Clin Pharm; 2016 Aug; 38(4):985-95. PubMed ID: 27286973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of CHA
    van Doorn S; Rutten FH; O'Flynn CM; Oudega R; Hoes AW; Moons KGM; Geersing GJ
    Int J Cardiol; 2018 Dec; 273():123-129. PubMed ID: 30224261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation: physician and patient perspectives.
    Alonso-Coello P; Montori VM; Díaz MG; Devereaux PJ; Mas G; Diez AI; Solà I; Roura M; Souto JC; Oliver S; Ruiz R; Coll-Vinent B; Gich I; Schünemann HJ; Guyatt G
    Health Expect; 2015 Dec; 18(6):2318-27. PubMed ID: 24813058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a patient decision aid (PDA) for type 2 diabetes on knowledge, decisional self-efficacy, and decisional conflict.
    Bailey RA; Pfeifer M; Shillington AC; Harshaw Q; Funnell MM; VanWingen J; Col N
    BMC Health Serv Res; 2016 Jan; 16():10. PubMed ID: 26762150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient Decision Aid (PDA) for Patients with Rheumatoid Arthritis Reduces Decisional Conflict and Improves Readiness for Treatment Decision Making.
    Pablos JL; Jover JA; Roman-Ivorra JA; Inciarte-Mundo J; Dilla T; Sacristan JA; Comellas M; Lizán L
    Patient; 2020 Feb; 13(1):57-69. PubMed ID: 31410723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.